General Statement of Disclosure:

CONSULTING FEES/HONORARIA: AstraZeneca Pharmaceuticals(SIGNIFICANT), Diamedica(MODEST), NxStage(SIGNIFICANT), Relypsa(SIGNIFICANT), Bayer(SIGNIFICANT), Pfizer(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: General Electric(MODEST), Merck(SIGNIFICANT), Johnson & Johnson(SIGNIFICANT), Boston Scientific(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Relypsa(SIGNIFICANT), University of British Columbia(SIGNIFICANT), National Institute of Health (NHLBI)(SIGNIFICANT) OTHER FINANCIAL BENEFIT: UpToDate(MODEST), Bristol-Myers Squibb Company (SIGNIFICANT)

View Full Disclosure